Cardiology and Therapy
Neurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World Study
By Nowell Mark Fine, Nicholas S. Streicher, Isabel M. Conceição, Show 5 more authorsFarooq H. Sheikh
Cohort study of 67 peopleInterventions
35.0 months, multicentre, registered NCT06393465, declared ties to: Pfizer, AstraZeneca, Janssen and 28 more
- Tafamidis
- TTR
- Transthyretin amyloidosis
- Essential Frailty Toolset
- Medical Research Council Scale for Muscle Strength
- Humans
The paper
University of Calgary; Georgetown University
Cardiology and Therapy, 7 Oct 2026
